Effects of etybenzatropine and diazepam on levodopa‐induced diphasic dyskinesias in Parkinson's disease
Identifieur interne : 003466 ( Istex/Curation ); précédent : 003465; suivant : 003467Effects of etybenzatropine and diazepam on levodopa‐induced diphasic dyskinesias in Parkinson's disease
Auteurs : Emmanuelle Pourcher [France] ; Anne-Marie Bonnet [France] ; John Kefalos [France] ; Bruno Dubois [France] ; Agid [France]Source :
- Movement Disorders [ 0885-3185 ] ; 1989.
English descriptors
- KwdEn :
Abstract
Levodopa‐induced onset and end‐of‐dose dyskinesia are rare but disabling disorders. Although they can be attenuated by increasing and dividing the daily dose of levodopa, this does not constitute a therapeutic approach. In this pilot study, etybenzatropine, an anticholinergic drug, and diazepam, a selective benzodiazepine, were administered in addition to a single dose of levodopa in nine patients with Parkinson's disease. Both drugs tended to decrease the severity and the duration of onset and end‐of‐dose dyskinesia, and to increase the duration of action of levodopa on parkinsonian symptoms.
Url:
DOI: 10.1002/mds.870040301
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003466
Links to Exploration step
ISTEX:A0A1EF877A89AD91DC3BFBC1A4B1A1C73054D518Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effects of etybenzatropine and diazepam on levodopa‐induced diphasic dyskinesias in Parkinson's disease</title><author><name sortKey="Pourcher, Emmanuelle" sort="Pourcher, Emmanuelle" uniqKey="Pourcher E" first="Emmanuelle" last="Pourcher">Emmanuelle Pourcher</name><affiliation wicri:level="1"><mods:affiliation>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Bonnet, Anne Arie" sort="Bonnet, Anne Arie" uniqKey="Bonnet A" first="Anne-Marie" last="Bonnet">Anne-Marie Bonnet</name><affiliation wicri:level="1"><mods:affiliation>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Kefalos, John" sort="Kefalos, John" uniqKey="Kefalos J" first="John" last="Kefalos">John Kefalos</name><affiliation wicri:level="1"><mods:affiliation>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name><affiliation wicri:level="1"><mods:affiliation>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Agid" sort="Agid" uniqKey="Agid" last="Agid">Agid</name><affiliation wicri:level="1"><mods:affiliation>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A0A1EF877A89AD91DC3BFBC1A4B1A1C73054D518</idno><date when="1989" year="1989">1989</date><idno type="doi">10.1002/mds.870040301</idno><idno type="url">https://api.istex.fr/document/A0A1EF877A89AD91DC3BFBC1A4B1A1C73054D518/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003466</idno><idno type="wicri:Area/Istex/Curation">003466</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Effects of etybenzatropine and diazepam on levodopa‐induced diphasic dyskinesias in Parkinson's disease</title><author><name sortKey="Pourcher, Emmanuelle" sort="Pourcher, Emmanuelle" uniqKey="Pourcher E" first="Emmanuelle" last="Pourcher">Emmanuelle Pourcher</name><affiliation wicri:level="1"><mods:affiliation>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Bonnet, Anne Arie" sort="Bonnet, Anne Arie" uniqKey="Bonnet A" first="Anne-Marie" last="Bonnet">Anne-Marie Bonnet</name><affiliation wicri:level="1"><mods:affiliation>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Kefalos, John" sort="Kefalos, John" uniqKey="Kefalos J" first="John" last="Kefalos">John Kefalos</name><affiliation wicri:level="1"><mods:affiliation>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name><affiliation wicri:level="1"><mods:affiliation>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Agid" sort="Agid" uniqKey="Agid" last="Agid">Agid</name><affiliation wicri:level="1"><mods:affiliation>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinique de Neurologie et Neuropsychologie and INSERM U 289, Paris</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1989">1989</date><biblScope unit="vol">4</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="195">195</biblScope><biblScope unit="page" to="201">201</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">A0A1EF877A89AD91DC3BFBC1A4B1A1C73054D518</idno><idno type="DOI">10.1002/mds.870040301</idno><idno type="ArticleID">MDS870040301</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Diazepam</term><term>Dyskinesias</term><term>Etybenzatropine</term><term>Levodopa</term><term>Parkinson's Disease</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Levodopa‐induced onset and end‐of‐dose dyskinesia are rare but disabling disorders. Although they can be attenuated by increasing and dividing the daily dose of levodopa, this does not constitute a therapeutic approach. In this pilot study, etybenzatropine, an anticholinergic drug, and diazepam, a selective benzodiazepine, were administered in addition to a single dose of levodopa in nine patients with Parkinson's disease. Both drugs tended to decrease the severity and the duration of onset and end‐of‐dose dyskinesia, and to increase the duration of action of levodopa on parkinsonian symptoms.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003466 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 003466 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:A0A1EF877A89AD91DC3BFBC1A4B1A1C73054D518
|texte= Effects of etybenzatropine and diazepam on levodopa‐induced diphasic dyskinesias in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |